Xiaoling Ling
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 4
- Oncology 7
- HER2/EGFR in Cancer Research 3
- Vascular Tumors and Angiosarcomas 1
- Cancer Cells and Metastasis 1
- Co-authors
- Da Zhao (3 shared papers)Bingxue Yan (1 shared paper)Quanlin Guan (1 shared paper)Xiaoming Hou (2 shared papers)Fei Su (5 shared papers)Tao Zhang (4 shared papers)Yongbin Lu (5 shared papers)Xiaoying Xu (1 shared paper)
In The Last Decade
Xiaoling Ling
17 papers receiving 296 citations
Peers
Comparison fields: 5 of 42
- Cancer Research 95
- Oncology 48
- Molecular Biology 115
- Endocrinology, Diabetes and Metabolism 25
- Complementary and alternative medicine 7
Countries citing papers authored by Xiaoling Ling
This map shows the geographic impact of Xiaoling Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Ling more than expected).
Fields of papers citing papers by Xiaoling Ling
This network shows the impact of papers produced by Xiaoling Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Ling. The network helps show where Xiaoling Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2019 | 57 | |
| 3 | 2009 | 34 | |
| 4 | 2020 | 25 | |
| 5 | 2022 | 18 | |
| 6 | 2024 | 18 | |
| 7 | 2023 | 15 | |
| 8 | 2024 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2015 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2014 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2021 | 3 | |
| 15 | 2023 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2026 | 0 | |
| 19 | 2026 | 0 | |
| 20 | 2026 | 0 |
About Xiaoling Ling
Xiaoling Ling is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Experimental and Cognitive Psychology, having authored 20 papers that have together received 305 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (2 papers), Sleep and related disorders (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Nausea and vomiting management (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Cancer Research (95 citations), Oncology (48 citations), Molecular Biology (115 citations), Endocrinology, Diabetes and Metabolism (25 citations) and Complementary and alternative medicine (7 citations). Xiaoling Ling has collaborated with scholars based in China and Canada. Frequent co-authors include Da Zhao, Bingxue Yan, Quanlin Guan, Xiaoming Hou, Fei Su, Tao Zhang, Yongbin Lu, Xiaoying Xu, Yi Xiao and Xing-Xu Zhao. Their work appears in journals such as Frontiers in Oncology, Breast Cancer, Oxidative Medicine and Cellular Longevity, Cancer Cell International and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.